New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Roche hepatitis C assay: Roche Diagnostics will start shipping its Elecsys Anti-HCV antibody to hepatitis C virus assay, indicated for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma, in July, the firm announced May 28. FDA granted PMA approvals for use of the test on three platforms: the stand-alone cobas e 411 analyzer for low-volume testing; and the cobas e 601 and Modular Analytics E 170 analyzers for mid- and high-volume testing, respectively. The anti-HCV assay is an 18-minute test designed for use with Roche's electrochemiluminescence technology. Roche received 510(k) clearance for another immunoassay, Rubella IgM, in April ("1The Gray Sheet" April 12, 2010)